Analisis Karakteristik Pasien Tuberkulosis Paru di Puskesmas Cibaduyut Kidul Tahun 2024-2025
Analysis of Pulmonary Tuberculosis Patient Characteristics at Puskesmas Cibaduyut Kidul in 2024-2025
DOI:
https://doi.org/10.30872/Keywords:
Tuberkulosis, Tuberkulosis Paru, tuberkulosis resistan obat, Mycobacterium tuberculosisAbstract
References
[1] J. W. Saelens, G. Viswanathan, dan D. M. Tobin, “Mycobacterial Evolution Intersects With Host Tolerance,” 2019. doi: 10.3389/fimmu.2019.00528.
[2] K. Basalingappa et al., “Tuberculosis – An overview,” Indian J. Microbiol. Res., 2021, doi: 10.18231/j.ijmr.2021.019.
[3] G. Davidson et al., “Overview of Tuberculosis: Causes, Symptoms and Risk Factors,” Asian J. Res. Infect. Dis., 2024, doi: 10.9734/ajrid/2024/v15i9370.
[4] B. N. P. Kumar et al., “Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica–Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer,” Mol. Pharm., vol. 15, no. 7, hal. 2698–2713, Jul 2018, doi: 10.1021/acs.molpharmaceut.8b00218.
[5] C. A. McCarthy, D. Y. Zemlyanov, A. M. Crean, dan L. S. Taylor, “Comparison of Drug Release and Adsorption under Supersaturating Conditions for Ordered Mesoporous Silica with Indomethacin or Indomethacin Methyl Ester,” Mol. Pharm., vol. 17, no. 8, hal. 3062–3074, Agu 2020, doi: 10.1021/acs.molpharmaceut.0c00489.
[6] G. Migliori, C. Ong, L. Petrone, L. D’Ambrosio, R. Centis, dan D. Goletti, “The definition of tuberculosis infection based on the spectrum of tuberculosis disease,” Breathe, vol. 17, 2021, doi: 10.1183/20734735.0079-2021.
[7] K. Zaman, “Tuberculosis: A Global Health Problem,” J. Health. Popul. Nutr., vol. 28, hal. 111–113, 2010, doi: 10.3329/jhpn.v28i2.4879.
[8] World Health Organization, Global tuberculosis report 2025. 2025.
[9] Kementerian Kesehatan Republik Indonesia, Profil Kesehatan. 2024.
[10] F. Fahdhienie, M. Mudatsir, T. Abidin, dan N. Nurjannah, “Risk factors of pulmonary tuberculosis in Indonesia: A case-control study in a high disease prevalence region,” Narra J, vol. 4, 2024, doi: 10.52225/narra.v4i2.943.
[11] W. Bai dan E. Ameyaw, “Global, regional and national trends in tuberculosis incidence and main risk factors: a study using data from 2000 to 2021,” BMC Public Health, vol. 24, 2024, doi: 10.1186/s12889-023-17495-6.
[12] H. Li, C. Chee, T. Geng, A. Pan, dan W. Koh, “Joint associations of multiple lifestyle factors with risk of active tuberculosis in the population: the Singapore Chinese Health Study.,” Clin. Infect. Dis., 2021, doi: 10.1093/cid/ciab935.
[13] R. Duarte et al., “Tuberculosis, social determinants and co-morbidities (including HIV).,” Pulmonology, vol. 24 2, hal. 115–119, 2017, doi: 10.1016/j.rppnen.2017.11.003.
[14] J. Franco et al., “Diabetes as a risk factor for tuberculosis disease,” Cochrane Database Syst. Rev., vol. 2024, 2024, doi: 10.1002/14651858.cd016013.pub2.
[15] P. Narasimhan, J. Wood, C. MacIntyre, dan D. Mathai, “Risk Factors for Tuberculosis,” Pulm. Med., vol. 2013, 2013, doi: 10.1155/2013/828939.
[16] Y. Gelaw, Z. Getaneh, dan M. Melku, “Anemia as a risk factor for tuberculosis: a systematic review and meta-analysis,” Environ. Health Prev. Med., vol. 26, 2021, doi: 10.1186/s12199-020-00931-z.
[17] E. Groenweghe et al., “Outbreak of Multidrug-Resistant Tuberculosis — Kansas, 2021–2022,” 2023. doi: 10.15585/mmwr.mm7235a4.
[18] F. Mhimbira et al., “Prevalence and Clinical Relevance of Helminth Co-Infections Among Tuberculosis Patients in Urban Tanzania,” 2017. doi: 10.1371/journal.pntd.0005342.
[19] G. Durgeshwar et al., “Comparison of Diagnostic Yield and Complications in Ultrasound-Guided Closed Pleural Biopsy Versus Thoracoscopic Pleural Biopsy in Undiagnosed Exudative Pleural Effusion,” 2022. doi: 10.7759/cureus.23809.
[20] Kementerian Kesehatan Republik Indonesia, “PERATURAN MENTERI KESEHATAN REPUBLIK INDONESIA NOMOR 67 TAHUN 2016,” 2016.
[21] E. Osei, S. A. Oppong, dan J. Der, “Trends of Tuberculosis Case Detection, Mortality and Co-Infection With HIV in Ghana: A Retrospective Cohort Study,” 2020. doi: 10.1371/journal.pone.0234878.
[22] W. W. Aung et al., “Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium Tuberculosis Clinical Isolates in Myanmar,” 2018. doi: 10.1128/aac.01984-17.
[23] E. E. Evans et al., “Long Term Outcomes of Patients With Tuberculous Meningitis: The Impact of Drug Resistance,” 2022. doi: 10.1371/journal.pone.0270201.
[24] E. Paikray, M. Pattnaik, V. Mishra, P. A. Abhisek, S. S. Pradhan, dan A. Rout, “Evaluation of Health-Related Quality of Life and Adherence Among Pre-Extensively Drug-Resistant Tuberculosis Patients Receiving Either Bedaquiline or Delamanid Regimen at a Teaching Hospital in Eastern India,” J. Fam. Med. Prim. Care, vol. 13, no. 10, hal. 4684–4692, 2024, doi: 10.4103/jfmpc.jfmpc_572_24.
[25] N. Aitambayeva et al., “A Systematic Review of Tuberculosis Stigma Reduction Interventions,” Healthcare, vol. 13, no. 15, hal. 1846, 2025, doi: 10.3390/healthcare13151846.
[26] M. Mengesha, A. Tadesse, T. Gari, dan A. Zebdewos, “Determinants of Drug Resistant Tuberculosis Among Tuberculosis Patients on Treatment in Gedeo Zone Public Healthcare Facilities, Southern Ethiopia, 2025. Unmatched Case‒control Study.,” 2026. doi: 10.21203/rs.3.rs-8915478/v1.
[27] T. A. Jhaveri et al., “Barriers to Engagement in the Care Cascade for Tuberculosis Disease in India: A Systematic Review of Quantitative Studies,” 2024. doi: 10.1371/journal.pmed.1004409.
[28] S. J. Saabdulla, S. Baybayan, dan M. Asiri, “Treatment Adherence Among Patients With Pulmonary Tuberculosis in Jolo,” 2024. doi: 10.62596/1et6em44.
[29] F. Xie et al., “Evidence‐Based Summary on Medication Adherence Management for Adult Tuberculosis Patients With Multi‐Dimensional Strategies and Practice Framework,” 2025. doi: 10.1111/jep.70280.
[30] K. Dixit, “Understanding Psychosocial and Economic Barriers to Develop Innovative People-Centered Models of Tuberculosis Care in Nepal,” 2024. doi: 10.69622/26977144.v1.
[31] J. N. Sekandi et al., “Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial,” 2021. doi: 10.2196/18029.
[32] N. F. Baloyi dan Z. M. Manyisa, “Patients’ Perceptions on the Factors Contributing to Non-Conversion After Two Months of Tuberculosis Treatment at Selected Primary Healthcare Facilities in the Ekurhuleni Health District, South Africa,” 2022. doi: 10.2174/18749445-v15-e2208291.
[33] R. B. Pratiwi, “Depression Among Tuberculosis Patients and Its Association With Medication Adherence of Anti-Tuberculosis Drugs Literature Review,” 2024. doi: 10.56338/mppki.v7i7.5337.
[34] C. C. Mendes, R. J. G. Unger, T. C. de Araújo-Jorge, dan A. C. C. Carvalho, “Tuberculosis in Adolescence: An Integrative Review Focusing on Patient-Centered Care,” Rev. Paul. Pediatr., vol. 42, 2024, doi: 10.1590/1984-0462/2024/42/2023027.
[35] A. Setiyadi, U. Noviana, E. N. Sholikhah, A. Akhmadi, dan H. Mufarokhah, “Community Empowerment Through Cadres in the Tuberculosis Program: A Scoping Review,” 2025. doi: 10.18502/ijph.v54i7.19113.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Sains dan Kesehatan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/jskff/public_html/plugins/generic/citations/CitationsPlugin.php on line 68
How to Cite
Similar Articles
- Akhmad Jaizzur Rijai, Asep Gana Suganda, Elin Yulinah Iskandar, Aktivitas Inhibitor Alfa-Amilase Beberapa Tumbuhan Obat Indonesia , Jurnal Sains dan Kesehatan: Vol. 1 No. 10 (2018): J. Sains Kes.
- Amelia Lorensia, Doddy de Queljoe, Yessica Christina Wijaya Tandjung, Profil Kelengkapan Informasi oleh Apoteker tentang Cara Penggunaan Sediaan Handihaler® yang Mengandung Tiotropium Bromida Di Apotek Wilayah Surabaya Timur , Jurnal Sains dan Kesehatan: Vol. 2 No. 1 (2019): J. Sains Kes.
- Jamaludin Al Jamaludin Efendi, Ekanita Desiani, Amanda Kusumaning Astari, Analisis Penggunaan E-purchasing pada Pengadaan Obat Esensial di Dinas Kesehatan Kota Pekalongan , Jurnal Sains dan Kesehatan: Vol. 5 No. 1 (2023): J. Sains Kes.
- Risna Agustina, Nurul Annisa, Wisnu Cahyo Prabowo , Potensi Interaksi Obat Resep Pasien Hipertensi di Salah Satu Rumah Sakit Pemerintah di Kota Samarinda , Jurnal Sains dan Kesehatan: Vol. 1 No. 4 (2015): J. Sains Kes.
- Okta Muthia Sari, Aditya Maulana Perdana Putra, Yusrinie Wasiaturrahmah, Nahdiya Rahmah, Analisis Faktor yang Berhubungan dengan Potensi Interaksi Obat Pasien Covid-19 di Salah Satu Rumah Sakit Kalimantan Selatan , Jurnal Sains dan Kesehatan: Vol. 5 No. 5 (2023): J. Sains Kes.
- Swandari Paramita, Ronny Isnuwardana, Muhammad Khairul Nuryanto, Ruth Djalung, Dewi Guntar Rachmawatiningtyas, Prilandy Jayastri , Pola Penggunaan Obat Bahan Alam Sebagai Terapi Komplementer pada Pasien Hipertensi Di Puskesmas , Jurnal Sains dan Kesehatan: Vol. 1 No. 7 (2017): J. Sains Kes.
- Erlin Oktavia, Amelia Lorensia, Rivan Virlando Suryadinata, Pengaruh Jenis dan Pola Konsumsi Makanan yang Mengandung Vitamin D Terkait Gangguan Fungsi Paru pada Tukang Bangunan , Jurnal Sains dan Kesehatan: Vol. 5 No. 5 (2023): J. Sains Kes.
- Rahmi Indiani, Mally Ghinan Sholih, Indah Laily Hilmi, Faktor yang Mempengaruhi Penggunaan Obat Kategori Over the Counter pada Mahasiswa UNSIKA , Jurnal Sains dan Kesehatan: Vol. 5 No. 4 (2023): J. Sains Kes.
- Ani Anggriani, Pujani Utami, Ida Lisni, Kajian Potensi Interaksi Obat Pada Pasien Glaukoma di Salah Satu Rumah Sakit di Bandung , Jurnal Sains dan Kesehatan: Vol. 1 No. 5 (2016): J. Sains Kes.
- Adam M. Ramadhan, Laode Rijai, Jeny Maryani Liu, Kajian Penggunaan Obat Hipoglikemik Oral pada Pasien Diabetes Mellitus Tipe 2 di Puskesmas Temindung Samarinda , Jurnal Sains dan Kesehatan: Vol. 1 No. 3 (2015): J. Sains Kes.
You may also start an advanced similarity search for this article.

